期刊文献+

含积雪草提取物的药物和化妆品用于抗炎和预防皮肤衰老等 被引量:1

原文传递
导出
摘要 积雪草提取物含羟基积雪草苷和terminoloside。积雪草地上部分用乙醇提取,提取液过阴离子树脂,用脱脂洗脱液洗脱,浓缩挥尽醇后过滤,滤液依次经阳离子树脂和阴离子树脂处理,加醇稳定,色谱分析,得到含量大于95%的羟基积雪草苷和terminoloside混合物,其中积雪草苷的含量为30%~70%。该提取物具抗炎活性。用于自身免疫病、慢性炎症和肠胃病,也用于治疗牛皮癣、
作者 田成旺
出处 《国外医药(植物药分册)》 2005年第2期88-89,共2页
  • 相关文献

同被引文献14

  • 1Gabriel SE.The epidemiology of rheumatoid arthritis[J].Rheum Dis Clin North Am,2001,27:269-282.
  • 2Mabato SB,Sahu NP,Luger P,et al.Stereochemistry of a trisaccharide from Centella asiatica.X-Ray determination of the structure of asiaticoside[J].J Chem Soc Perkin Trans Ⅱ,1987:1509.
  • 3Trentham DE,Townes AS,Kang AH.Autoimmunity to type Ⅱ collagen an experimental model of arthritis[J].J Exp Med,1977,146:857-868.
  • 4Banda NK,Kraus D,Vondracek A,et al.Mechanisms of effects of complement inhibition in murine collagen-induced arthritis[J].Arthritis Rheum,2002,46:3065-3075.
  • 5Tomita T,Kakiuchi Y,Tsao PS.THR0921,a novel peroxisome proliferators activated receptor gamma agonist,reduces the severity of collagen-induced arthritis[J].Arthritis Res Ther,2005,8:10-18.
  • 6Haqqi TM,Anthony DD,Gupta S,et al.Prevention of collagen-induced arthritis in mice by a polyphenolic fraction from green tea[J].Proc Natl Acad Sci,1999,96:4524-4529.
  • 7Brand DD,Myers LK,Whittington KB.Detection of early changes in autoimmune T cell phenotype and function following intravenous administration of type Ⅱ collagen in a TCR-transgenic model[J].J Immunol,2002,168:490-498.
  • 8Lipsky PE.Role of cyclooxygenase-1 and -2 in health and disease[J].Am J Orthop,1999,28:8-12.
  • 9Ochi T,Ohkubo Y,Mutoh S.Role of cyclooxygenase-2,but not cyclooxygenase-1,on type II collagen-induced arthritis in DBA/1J mice[J].Biochem Pharmacol,2003,66:1055-1060.
  • 10Akaogi J,Nozaki T,Satoh M,et al.Role of PGE2 and EP receptors in the pathogenesis of rheumatoid arthritis and as a novel therapeutic strategy[J].Endocr Metab Immune Disord Drug Targets,2006,6:383-394.

引证文献1

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部